ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, Numbers are in Thousands) announced record-setting fourth quarter and year-end performance numbers. The Company recorded Q4FY08 revenues of $81,236, the best ever quarter in terms of revenues in corporate history and an increase of 16% over the $69,795 recorded in the fourth quarter, fiscal year 2007. Net income before taxes in Q4FY08 totaled $9,335; an increase of 19% compared with net income before taxes of $7,855 in Q4FY07. Net income after tax for Q4FY08 totaled $5,245 or $.38 per share as compared with $4,644 or $.33 per share in the corresponding quarter in FY07. Gross profits on revenues for the current quarter were $40,801 resulting in a margin for gross profit on revenues of 50%, versus the $36,191 reported for the prior fiscal year fourth quarter, resulting in a slightly higher margin of 52%. Revenue per patient for the fourth quarter of the current fiscal year was $78.22, an increase of 10% over the $71.06 reported for the same quarter of the prior fiscal year. The number of patients served increased 6% to 1029 in the current quarter from the prior year fourth quarter total of 972. Esoteric business for the Company increased to 50% of revenues for the fourth quarter of the current fiscal year.
